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 ABSTRACT 
 
PERI-IMPLANTITIS RISK PREDICTION USING A COMPUTER 
BASED PERIODONTAL RISK CALCULATOR TOOL: A 
RETROSPECTIVE STUDY. 
Walaa Al Zaibak, BDS 
 
Marquette University, 2020 
 
 
Introduction: Although literature is abundant on the diagnosis and management of peri-
implantitis after it has occurred, to our current knowledge there are no studies that have 
specifically looked into the relationship between peri-implantitis and the periodontal risk 
assessment tool used for natural dentitions. 
 
Material and Methods: In this retrospective study, the patient population included 
patients (>20 years of age) who had implants placed and restored at Marquette University 
School of Dentistry (MUSOD) from 2008 to 2016. Further, the restored implants in these 
patients must have been in function for at least one year and followed up in the school 
with clinical and radiographic examinations. Patients excluded from the study were those 
who had radiation therapy, or any patients who did not have acceptable radiographs for 
proper documentation.  Before collecting data from patients' existing records, approval 
was obtained from MUSoD's Institutional Review Board. Patient records were screened 
from a list of 1,496 patients who had 3,032 implants placed at the school between the 
mentioned period. A total of 112 implants placed in 83 patients were included for 
analysis.  
 
Results: All	cases	with	PRC	of	1	were	in	the	control	group	while	all	cases	with	PRC	of	4	 and	 5	 were	 in	 the	 test	 group.	 Average	 proximal	 bone	 loss	 was	 significantly	correlated	with	PRC	scores.	The	patients	with	higher	PRC	scores	had	more	average	proximal	bone	loss	when	measured	radiographically.		Average	proximal	bone	loss	in	the	control	group	was	0.11mm	and	in	the	peri-implantitis	group	was	2.48	mm.	 
 
Conclusions: Periodontal risk calculator may be used to predict risk of periimplantitis 
occurrence and degree of radiographic proximal bone loss around dental implants.  
Higher PRC scores were correlated with higher bone loss and lower PRC scores were 
correlated with reduced severity of bone loss.
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INTRODUCTION 
 
Dental implants have been widely used as a standard treatment option for restoring missing 
teeth as an alternative to removable and fixed dental prosthesis. In the year 2000, it was 
reported that an estimate of 300,000 to 428,000 implants were placed yearly.1 A 
significantly higher success rate is observed for implants placed in the mandibular than the 
maxillary arch.2 Studies have previously described specific criteria for evaluating implant 
success. These include an absence of any signs and symptoms such as pain, infection, 
neuropathies, vital structure violation, mobility, peri-implant radiolucency, or progressive 
bone loss.1 
Dental implants have been shown to achieve almost 85-95% 10-year success rate when 
placed in complete and partially edentulous maxillary and mandibular arches.3 The success 
of implants is directly correlated with a process called osseointegration. Osseointegration 
at the light microscopic level, is defined as a direct structural connection between living 
bone and functionally loaded implants.4 
Endosseous dental implants are available in a variety of lengths and widths to suit different 
clinical situations.1 Most implants today have a roughened surface as compared to 
previously used smooth or machined surfaces. Roughened surface implants are thought to 
be superior to the smooth surface implants because roughened surface implants show 
higher bone to implant contacts with more significant potential for osseointegration. Either 
coating or non-coating techniques may be used to create the rough surfaces on implants.  
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Peri-implant disease:  
A large number of patients requiring implant therapy have a history of chronic 
periodontitis. Restoring these patients with dental implants has become a common practice. 
Long-term studies have shown patients with chronic periodontitis to have increased 
susceptibility to peri-implant complications, most common being peri-implant mucositis 
and peri-implantitis. Extensive literature has reported poor oral hygiene, smoking, and 
history of chronic periodontal disease to be risk indicators for the development of peri-
implantitis. Also, it was found that patients with history of periodontitis had a significantly 
greater prevalence of peri-implant sites with plaque, bleeding on probing and deep pocket 
depth.5,6  
Peri-implant mucositis is defined as a reversible inflammation resulting in bleeding on 
probing without peri-implant bone loss. Peri-implantitis is defined as an inflammation 
affecting hard and soft tissues around a dental implant. It is considered acceptable to have 
1.5mm of bone loss during the first year of function as the biologic width establishes itself 
around the implant abutment junction and subsequently, 0.2mm loss yearly.7  Berglundh 
and Lindhe in 1996 stated bone resorption may occur to allow for formation of a stable soft 
tissue attachment and maintain a minimum width of peri-implant mucosa.8 Several criteria 
have been described in the literature for diagnosis of peri-implantitis. According to the 
2017 world workshop on the classification of periodontal and peri-implant diseases and 
conditions, peri-implantitis is a plaque associated pathological condition that leads to 
progressive loss of bone around dental implants.9 For a diagnosis of peri-implantitis, the 
presence of bleeding on probing and/or suppuration on probing, increased probing depth 
and bone loss past the level of expected initial remodeling must be present. Diagnosis may 
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also be made in the absence of previous records if there is ≥ 6 mm of probing depth and ≥ 
3 mm of radiographic bone loss around the implant with clinical bleeding on probing and/or 
suppuration.9 Onset of peri-implantitis usually occurs 2-3 years after implant loading.10 The 
amount of initial remodeling that occurs after implant placement is variable and may be 
affected by several local and systemic factors, therefore baseline radiographs should ideally 
be made after the loading phase has occurred.9 
Prevalence of peri-implant disease:  
Prevalence of peri-implantitis has been reported by several studies. Buser and co-workers 
assessed 303 tissue level implants, with sandblasted and acid etched surfaces, over 10 years 
of function and found prevalence of peri-implantitis to be 1.8%.11 This low prevalence may 
be partially related to the implant design, featuring a polished transmucosal collar and 
internal connection. This type of design moves the microgap between the implant and 
abutment coronally, away from the crestal bone and so should theoretically reduce the 
bacterial challenge on the crestal bone.5,12 However, this displacement of the implant-
abutment microgap is not exclusive to the tissue level design and may also be accomplished 
by a horizontal offset in bone level implants commonly referred to as platform switching. 
Platform switching has been shown in the literature to reduce the risk of peri-implant bone 
loss.13 
Frisch and colleagues followed up on 36 non-smoking patients with implants placed for ≥ 
10 years and found prevalence of peri-implantitis in maxillary and mandibular implant 
supported overdentures was 9.1% at the patient level after a mean follow up of 14 years.14 
Marrone and wo-workers, in 2012, assessed prevalence of peri-mucositis peri-implantitis 
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in 103 patients with a total of 266 implants with an average of 8.5 years of function. Their 
results showed 38 % of implants had peri-implant mucositis while 23 % had peri-
implantitis.15 The varying ranges in prevalence of peri-implantitis reported in the literature 
may be, in part, attributed to the lack of consensus in diagnostic criteria and the 
heterogenicity in the studies.16 Other factors that may play a role in the varying ranges 
reported include different implant systems, designs and surfaces as well as the varying 
experience levels of clinicians placing these implants. 
Renvert and co-workers in 2017 reported results for 86 patients who had 351 Branemark 
dental implants placed and followed up for 20-26 years. They found 54.7% of implant 
developed peri-implant mucositis, while 22.1 % developed peri-implantitis. They also 
found that smoking, a diagnosis of peri-implant mucositis and radiographic evidence of 
periodontitis were not significantly correlated with developing peri-implantitis. Patients 
who had 3 or more implants were at higher risk of developing peri-implantitis.17 
Risk determination for peri-implant disease: 
Both peri-implant mucositis and peri-implantitis may be caused by inadequate oral hygiene 
and plaque or residual cement from crown placement.7 Peri-implant mucositis may be a 
precursor to peri-implantitis. However, it does not always progress in that manner.18 The 
shift from peri-implant mucositis to peri-implantitis is not fully understood, however it has 
been proposed that it is likely to be similar to the progression from gingivitis to 
periodontitis.19 
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Plaque is considered to be a principal etiological factor for peri-implantitis. This evidence 
is mostly derived from observational studies showing that poor oral hygiene and negligence 
in maintenance care increases the risk of peri-implantitis.9 
Treatment of peri-implantitis has the same end goal as treatment of periodontitis, that is to 
prevent the progression of bone loss. Successful therapy should ideally also eliminate 
pockets and bleeding on probing, indicating clinical resolution of inflammation.19 
For the longest time, an accepted patient care practice was to focus on restoring oral health 
rather than preventing disease. A relatively new trend has emerged in using patient-specific 
risk assessment to prevent progression of periodontal disease or to enable primary 
prevention of disease by using a computer-based tool known as Periodontal risk calculator 
(PRC). PRC has been validated as a tool that provides an algorithm that seems to predict 
alveolar bone and tooth loss.20 This tool is being used as an aid in the treatment planning 
and management of dental patients. The PRC is based on a proprietary algorithm that uses 
commonly known risk factors affecting patients’ susceptibility for developing periodontal 
disease. It helps generate patient specific treatment options to strategically reduce risk 
factors and repair existing damage. Once the PRC assessment is completed, each patient is 
given a score from 1 (low risk) to 5 (high risk). The PRC protocol requires recording patient 
history and completing a periodontal examination.20  
Although literature is abundant on the diagnosis and management of peri-implantitis after 
it has occurred, to our current knowledge there are no studies that have specifically looked 
into the relationship between peri-implantitis and the periodontal risk assessment tool used 
for natural dentitions. 
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BACKGROUND AND SIGNIFICANCE 
 
Implants are regularly used to replace periodontally involved teeth and are at higher risk of 
peri-implant disease when placed in patients with a history of periodontitis.5 Peri-implant 
tissues tend to be more prone to inflammation as compared to periodontal tissue supporting 
natural teeth. The susceptibility of peri-implant tissue is especially true when looking at 
two-piece, non-platform switched implants.5,13 The micro-gap present between the implant 
and the abutment creates a zone of chronic inflammatory cells around the peri-implant 
tissues. One-piece implants have been reported to have an inflammation free peri-implant 
tissue.5  
 
Bacterial Biofilm  
To assess the bacterial biofilm of peri-implantitis Shibli and colleagues, in 2008, looked at 
the microbiological composition of supra- and subgingival plaque samples collected from 
44 subjects with peri-implantitis affecting a single implant, who also had a healthy implant 
as a control. All the implants had been in function for a minimum of 2 years before a 
diagnosis of peri-implantitis was made. Supra and subgingival plaque samples were 
collected from the sites exhibiting the deepest pockets using sterile plastic curettes. All 
samples were processed separately, and checkerboard DNA-DNA hybridization was done. 
The results showed that the composition for both supra- and subgingival samples differed 
significantly in peri-implantitis sites than in sites with healthy implants. Peri-implantitis 
sites were associated with pathogenic periodontal bacterial species such as Porphyromonas 
gingivalis, Treponema denticola, and Tannerella forsythia.21   
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In 2011, Mombelli and co-workers reviewed 29 articles on the characteristics of biofilms 
in peri-implant disease and found that biofilms in peri-implant disease were predominantly 
gram-negative anaerobic flora similar to that seen in the subgingival environment of 
chronic periodontitis. These	include	Fusobacterium	spp.	and	Prevotella	intermedia.22  
Koyanagi and co-workers, in 2013, looked specifically at subgingival plaque specimens of 
peri-implantitis sites and periodontitis sites. They used sterile paper points to collect 
subgingival plaque samples from the deepest pockets of peri-implantitis sites and non-
adjacent periodontitis sites in 6 patients. The paper points were inserted into the pockets 
until resistance was felt for 30 seconds and then placed in a sterile tube containing 1ml of 
distilled water and taken for processing and incubation. After quantitative analysis, they 
found that the prevalence of periodontally pathogenic bacteria was even higher at peri-
implantitis sites than at periodontitis sites.23  
In 2014, Da Silva and colleagues further support previous studies in their findings. They 
tested 20 subjects with peri-implantitis and periodontally healthy remaining dentition. Ten 
of the subjects had healthy implants as well to act as a control. Samples were collected 
from the deepest pocket sites using sterile Gracey curettes and then subjected to bacterial 
lysis and Polymerase chain reaction amplification. Their results showed remarkable 
differences in the composition of the subgingival biofilm between healthy and diseased 
implants. The biofilm associated with peri-implantitis sites showed more pathogenic 
bacterial species composition than healthy implant sites. These included some pathogenic 
bacterial species associated with periodontitis but also some unexpected putative 
pathogens.24 
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Becker and co-workers, in 2014, aimed to assess mRNA signatures from tissue samples 
excised from 22 patients isolating areas of peri-implantitis, periodontitis, and healthy 
controls.  They found signatures to be significantly different between peri-implantitis and 
periodontitis sites. Furthermore, they found that the regulation of transcripts in peri-
implantitis tissues was mainly related to the innate immune response including cell surface 
receptor signaling pathways and defense responses. Transcripts in periodontitis were 
mainly related to bacterial responses including response to molecules of bacterial origin 
and mononuclear cell proliferation.25   
Yet another publication that supports a similarity between microbiota at peri-implantitis 
sites and periodontitis sites comes from Waal and colleagues 2017 who conducted a 
microbiological study comparing 85 patients suffering from peri-implantitis to 69 patients 
with healthy peri-implant tissue using culturing techniques. Association of disease status 
and various patient- and implant-level factors with microbial characteristics were explored. 
Their findings showed that there was a strong association for the presence of 
Porphyromonas gingivalis, Provetella intermedia, Tannerella forsythia, and Fusobacterium 
nucleatum to peri-implantitis, which are commonly isolated bacteria in periodontal 
disease.26  
Schincaglia and co-workers conducted a study in 2017 to compare the clinical and 
inflammatory response between natural teeth and implants after 2 weeks of impaired oral 
hygiene practices. Their results showed that while implants accumulated less plaque 
clinically, they displayed a trend towards more elevated inflammatory mediators. They also 
found that the microbiome profile and community structure was similar for teeth and 
implants.27 
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Author Methods Results 
Shibli et al. 2008 - Supra- and 
subgingival plaque 
samples collected 
from 44 subjects 
with peri-implantitis 
affecting a single 
implant.  
- Healthy implant 
from same subject 
as a control. 
Peri-implantitis sites were 
associated with pathogenic 
periodontal bacterial species 
such as: 
 
- Porphyromonas 
gingivalis 
- Treponema 
denticola 
- Tannerella forsythia 
Mombelli et. al. 2011 - Review article  
- 29 articles included  
Biofilms in peri-implant 
disease were predominantly 
gram-negative anaerobic 
flora similar to chronic 
periodontitis. 
Koyanagi et al. 2013 - Subgingival plaque 
specimens of peri-
implantitis sites and 
non-adjacent 
periodontitis sites in 
6 subjects. 
Periodontally pathogenic 
bacteria were even higher at 
peri-implantitis sites than at 
periodontitis sites. 
Da Silva et al. 2014 - 20 subjects with 
peri-implantitis and 
periodontally 
healthy remaining 
dentition.  
- Ten of the subjects 
had healthy 
implants as well to 
act as a control. 
Biofilm associated with 
peri-implantitis sites 
showed more pathogenic 
bacterial species 
composition than healthy 
implant sites.  
- Fusobacterium 
nucleatum 
- Dialister invisus 
- Streptococcus sp. 
- Filifactor alocis  
- Mitsuokella sp. 
Becker et al. 2014 - mRNA signatures 
from tissue samples 
excised from 22 
patients isolating 
areas of peri-
implantitis, 
- Regulation of 
transcripts in peri-
implantitis tissues 
was mainly related 
to the innate 
immune response.  
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periodontitis, and 
healthy controls.   
- Bacterial response 
systems dominated 
in periodontitis 
Waal et al. 2017 - 85 patients with 
peri-implantitis 
- 69 patients with 
healthy peri-implant 
tissue  
- Culturing done 
- Porphyromonas 
gingivalis 
- Provetella 
intermedia 
- Tannerella forsythia 
- Fusobacterium 
nucleatum  
Table 1. Summary of Microbiological studies. 
 
 
Factors associated with peri-implantitis:  
Peri-implantitis may occur due to several factors. To investigate the prevalence, etiology, 
and management of peri-implantitis and peri-mucositis Papathanasiou and co-workers 
conducted a survey of 280 periodontists in 2016. They concluded that peri-implant disease 
was commonly encountered in their practices in over 25% of the patients. They also 
reported that there was an absence of standard therapeutic protocol in treating this 
condition. There was a general agreement among the specialists that the etiology of peri-
implantitis was strongly correlated with oral hygiene and plaque, smoking, excess 
subgingival cement, inadequate keratinized tissue, poor systemic health and non-
compliance with maintenance schedule.28 
Of the factors listed, excess cement left behind during prosthesis insertion has been of great 
concern, and several authors have researched this area. Thomas Wilson, in 2009, examined 
39 consecutive patients with signs of peri-implant disease using a dental endoscope. Forty-
two test implants with peri-implant disease and 20 clinically healthy control implants were 
included. He found that excess cement was present in 81% of the test implants, and after 
removal of excess cement, 76% of those showed complete resolution of inflammation. The 
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findings of their study indicated that if excess cement was not left behind, cement-retained 
restorations might not necessarily pose a more significant threat of peri-implantitis. 
Another interesting finding of this study was that signs of peri-implant disease were found 
to appear as early as four months after cementation of the final prosthesis and as late as 
nine years or more. They questioned the predictability of the timeline for peri-implant 
disease progression to peri-implantitis.29 
Sailer and co-workers, in 2012, assessed the 5-year survival rate and complications of 
cement vs. screw-retained implant restorations. One of their findings was that cemented 
restorations displayed a higher incidence of peri-implantitis as compared to screw-retained 
restorations.30 
To assess whether single implant cemented restorations could be adequately evaluated 
clinically and radiographically for excess cement and cleaned satisfactorily during the 
insertion appointment, Linkevicius and colleagues, in 2013, conducted a clinical trial on 
53 patients undergoing prosthetic replacement of a single tooth supported by an implant. 
Implant restorations were fabricated to be cemented onto standard abutments intraorally 
and cleaned until deemed acceptable clinically and radiographically, then finally removed 
as one piece through pre-existing screw access opening in the crown. Areas of excess 
cement were evaluated after crown removal and were correlated to the depth of the 
cementation margin.  The results showed that varying amounts of excess cement were 
located on all restoration margins and that more remaining cement was found as the 
margins were located deeper within the sulcus.31 
Katafuchi and co-workers in 2017 conducted a cross sectional radiographic analysis of 168 
implants placed in 83 patients to assess the influence of restoration contours on the 
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prevalence of peri-implantitis. They reported that for bone level implants, there was a 
significant correlation between peri-implantitis and emergence angles of >30 degrees. A 
significant correlation was also found for peri-implantitis and convex emergence profiles. 
When the emergence profile was both convex and at an angle > 30 degrees, peri-implantitis 
prevalence was 37.8%.6 Yuseung Yi and colleagues, in 2020, conducted a similar study, 
performing a retrospective analysis of 169 patients with a diagnosis of peri-implantitis to 
assess the influence of prosthesis related factors on its occurrence. They also found a 
statistically significant association between peri-implantitis and emergence angles of ≥ 30 
degrees, as well as convex emergence profiles.32 These findings indicate that prosthesis 
design and contours have significant impact on the health of peri-implant tissues.6,32  
Several studies have looked for associations between peri-implantitis and periodontitis. 
Karoussis and colleagues, in 2003, conducted a 10-year prospective study looking at 89 
patients treated with implant therapy. They found that peri-implantitis was associated with 
smoking, general health condition, full mouth attachment loss, and probing pocket depth 
change over time.33  
Ong and colleagues conducted a systematic review in 2008 that included nine studies 
comparing implant outcomes in patients with a history of periodontitis versus non-
periodontitis patients. They found evidence that periodontitis patients experienced a higher 
rate of soft and hard tissue peri-implant complications.34 This supports Karoussis’s findings 
that peri-implantitis shows association with periodontitis and may similar risk factors. 
Marrone and colleagues, in 2012, found that patients with active periodontitis were 1.98 
times more likely to develop peri-implantitis compared to the control group.15  
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On the other hand, Cho-Yan Lee and wo-workers conducted a clinical trial in 2011 
comparing the prevalence of peri-implantitis among 30 periodontally compromised and 30 
periodontally healthy patients with five years follow-up. They found that implants placed 
in periodontally compromised patients displayed similar bone loss and peri-implantitis 
levels to those placed in periodontally healthy patients, given that there was adequate 
periodontal therapy and maintenance.35 This may indicate that the risk of developing peri-
implantitis may be controlled in the same way as periodontitis risk is controlled with 
adequate therapy and regular maintenance. However, it must be noted that the sample size 
in this study is relatively small and the patients were followed up over a short time frame 
when considering peri-implantitis occurrence. 
Since smoking is a significant risk factor for periodontitis, several studies have looked into 
finding an association between smoking and peri-implantitis. Haas and colleagues, in 1996, 
compared 107 smokers to 314 non-smokers with clinical and radiographic observations to 
assess peri-implant tissues. They found that smoking resulted in a higher level of bone loss 
around dental implants.36 Lindquist and colleagues, in 1997, found that there is a correlation 
between the number of cigarettes smoked per day and the amount of bone loss 
demonstrated around implants.37 Al Harthi and co-workers, in 2017, conducted a 
retrospective study to investigate the prevalence of peri-implantitis in waterpipe smokers, 
cigarette smokers, and non-smokers. The results showed that peri-implantitis was 
significantly higher among waterpipe and cigarette smokers than non-smokers.38  
As for an association between diabetes and peri-implantitis, Monje and colleagues 
conducted a systematic review and meta-analysis in 2017, including 12 studies comparing 
the risk of peri-implantitis in diabetic versus non-diabetic patients. These 12 studies 
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comprised of 1,955 patients and 2892 implants. Among these patients, 12 patients were 
pre‐diabetic, 468 had diabetes, and 1,487 did not have diabetes. The authors found that 
diabetic patients had a 50% higher risk of developing peri-implantitis. They also found that 
there was a dose-dependent relationship between baseline HBA1c level and the occurrence 
of peri-implantitis.39 This finding could be an important factor in possibly using the PRC 
for predicting peri-implantitis as the PRC risk scores account for the presence and level of 
control in diabetes patients as part of their algorithm.40 
Al Zahrani in 2008 conducted a systematic review of nine articles looking at implant 
therapy in patients suffering from aggressive periodontitis. The study concluded that 
aggressive periodontitis patients display bone loss around dental implants more often than 
chronic periodontitis patients and periodontitis free patients. However, implant therapy was 
still feasible in these patients.41 
Lang & Berglundh in 2011, attributed peri-implantitis to several factors, including 
iatrogenic factors such as excess remnant cement, inadequate abutment seating, over 
contouring of implant restorations, implant malposition, and other technical 
complications.42 
Other factors that may be associated with bone loss around implants may include delayed 
vs immediate placement implants, staging, need for bone grafting, loading protocols, 
implant site and size and local infections.43,44 Biomechanical factors may include traumatic 
surgical technique, overheating the osteotomy site during surgery and implant 
overloading.43 
Lin and colleagues, in 2018, conducted a retrospective analysis of 20,959 implants to assess 
the risk factors associated with early and late implant loss. They found that late implant 
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failures (after occlusal loading) were significantly more common in patients that had bone 
augmentation procedures done.44 
Shin and colleagues in 2006 showed that less crestal bone loss occurs around roughened 
surface implants in comparison to machined surface implants.45 Depth of implant 
placement may also play a role as demonstrated by Stein and co-workers in 2009. Implants 
placed sub-crestally are more likely to experience bone loss at the coronal aspect of the 
implants.46 Although their study did not include platform switched implants, this may still 
be a relevant consideration when planning and placing implants.  
Susarla and coworkers in 2008 compared 1-year survival rates of immediately loaded 
implants versus implants loaded 3-6 months after placement. They found that immediately 
loaded implants are 2.7 times more likely to fail at 1 year than conventionally loaded 
implants. They also found tobacco use, maxillary implants and short implants were 
associated with higher failure rates.47 Block and co-workers in 2009 assessed the effects of 
immediate and delayed implant placement with provisionalization on bone and gingival 
response in the maxillary anterior region. Their study showed that bone levels were similar 
for both groups while more gingival recession was observed in the delayed placement 
group.48 Several authors agreed that slight crestal bone loss after immediate implant 
placement is an acceptable clinical outcome.49,51 Although other studies have shown that 
immediate implants can have similar performance to implants in healed ridges. This may 
be a testament to the technique sensitive nature of the procedure. Assuming adequate cases 
selection and clinical implementation, it should be assumed that immediate implant 
placement has similar outcomes to delayed placement.52   
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Performing 1-stage versus 2-stage implant placement may also affect success rates of 
dental implants. The 2-stage approach is considered by many to be the gold standard 
protocol for implant placement, however, may extend treatment time. When applying 1-
stage protocols, loading forces exceeding 150 microns may have detrimental effects in the 
healing phase. Troiano et. al. in 2018 conducted a systematic review to compare between 
success rates of 1-stage versus 2-stage implant healing. Their results showed that 1-stage 
implants have a 2% higher early failure rate than 2-stage implants.  
Linkevicius and colleagues, in 2009, evaluated the effect of soft tissue thickness on peri-
implant bone levels. Their study showed that up to 1.45 mm of crestal bone loss may be 
expected when soft tissue thickness was less than 2 mm.53 
Kumar and colleagues in 2018 conducted a retrospective analysis of 222 single implants in 
86 patients to assess site-level risk predictors of peri-implantitis, while controlling for 
patient level variables. They reported that a baseline plaque index of 1.6 or greater, history 
of tooth loss due to periodontitis, periodontal disease on adjacent teeth, deep implant 
placement and asymmetric prosthesis were all associated with peri-implantitis 
occurrence.54 
According to the 2017 world workshop on the classification of periodontal and peri-
implant diseases and conditions, major risk indicators for peri-implantitis are poor plaque 
control, history of severe periodontitis and lack of regular maintenance care.9 
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The purpose of this retrospective study was to assess the validity of using a computer-based 
periodontal risk calculator (PRC) score to assess the risk of developing peri-implantitis in 
the future.  
For the determination of risk scores, PRC requires information about patient age, history 
of smoking, diabetes, history of periodontal surgery, pocket depth, bleeding on probing, 
restoration below the gingival margin, root calculus, radiographic bone height, furcation 
involvements, and vertical bone lesions. A 15-year follow up study reported PRC to have 
a high level of accuracy in predicting the risk of periodontal bone loss and tooth loss.20 
Predicting future development of peri-implantitis before its occurrence could help dentists 
in making better treatment planning decisions and reducing treatment costs for patients. 
PRC could also help switch from the currently used repair to the wellness model of 
treatment during implant therapy. 	
The null hypothesis for this study was that patients with higher PRC scores are not at 
elevated risk for developing peri-implantitis.  
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MATERIAL AND METHODS 
 
In this retrospective study, the patient population included patients (>20 years of age) who 
had implants placed and restored at Marquette University School of Dentistry (MUSOD) 
from 2008 to 2016. Further, the restored implants in these patients must have been in 
function for at least one year and followed up in the school with clinical and radiographic 
examinations. Patients excluded from the study were those who had radiation therapy, or 
any patients who did not have acceptable radiographs for proper documentation.  Before 
collecting data from patients' existing records, approval was obtained from MUSoD's 
Institutional Review Board.  
 
Patient records were screened from a list of 1,496 patients who had 3,032 implants placed 
at the school between the mentioned period. A total of 112 implants placed in 83 patients 
were included for analysis. Eighty-two implants positive for peri-implantitis were included 
in the test group and 30 implants negative for peri-implantitis were included in the control 
group.  
Peri-implantitis was diagnosed according to Lang & Berglundh criteria, based on the 
stability of the radiographic bone level and clinical findings after loading of the implant 
prosthesis.42 Patients were diagnosed with peri-implantitis if there was evidence of 
progressive bone loss around an implant with bleeding on probing and/or suppuration.  
PRC records for the patients were retrospectively calculated within the same year of 
implant placement or, one year before implant placement. In addition, multiple variables 
were recorded including patient age, gender, smoking history, diabetes, hypertension, 
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presence or absence of periodontal disease, site of implant placement, type of restoration, 
radiographic bone height, implant information (brand, length and diameter), staging, bone 
grafting prior to placement, bone grafting at the time of placement, immediate vs. delayed 
implant placement. 
A baseline measurement was made using radiographs by measuring the bone level on the 
mesial and distal aspects at least one year after loading. The comparison was made using 
radiographs made in the most recent follow-up appointment. Bitewing radiographs were 
used for measurement when present. When bitewing radiographs were not available, 
periapical radiographs were used to measure the bone level. For a bone-level implant, bone 
loss was measured from the implant shoulder to the crestal bone. For Straumann tissue-
level implants, measurements were made similarly; however, the polished collar of the 
implant was subtracted from the measurements based on the known height of the polished 
collar.  
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Figure 1.  Showing mesial and distal crestal bone level measurements for Straumann 
4.1x10mm Standard plus tissue level implant at baseline. 1.8mm is subtracted from each 
of the measurements for this implant to account for the polished collar resulting in a final 
recording of 0.05mm and 0.18mm of bone loss on the mesial and distal aspects, 
respectively.  
 
 
Statistical analysis:  
All the patient characteristics and implants parameters were described using descriptive 
statistics. All category variables were described as frequency and percentage and two 
groups of patients (or implants) with or without disease were compared using Chi-Square 
or Fisher exact test wherever appropriate. Similarly, all the continuous numeric variables 
were described as mean and standard deviation and the two groups were compared using 
two-tailed t-test.  For the comparison of bone loss across the 5 PRC categories, one-way 
ANOVA was used and for multiple comparisons, Bonferroni test was used.  For time-to-
event (time in years of follow-up and event being peri-implantitis or no peri-implantitis) 
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analysis was done using multivariate Cox regression. For Cox regression implant 
characteristics were used as covariates. For all statistical test alpha of 0.05 significance 
level was used. Statistical analysis was performed using SAS version 9.4 (STAT 15.1), 
SAS Institute, Cary, NC.  
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RESULTS 
 
The mean age of the patients was 68.49 and ranged from 36 – 97 years of age. Binary 
genders were evenly distributed among the groups. No statistically significant difference 
was found between the peri-implantitis and peri-implant health groups with regard to 
smoking habits, history of diabetes or age, while hypertension was significantly more 
common in the peri-implantitis group.  
	
Figure	 2.	 Periapical	 radiograph	 showing	 advanced	 peri-implantitis	 lesions	 with	crater	like	appearance	on	two	adjacent	Nobel	Biocare	implants,	restored	with	cement	retained	lithium	disilicate	crowns	on	titanium	custom	abutments.					
At the implant level, no statistically significant difference was found for site, bone grafting 
before or at the time of placement, delayed vs immediate placement, 1 stage vs 2 stage or 
23 
 
type of restoration. Most of the implants were restored with cement-retained restorations 
(89%).  
All cases with PRC of 1 were in the control group while all cases with PRC of 4 and 5 were 
in the test group. Average proximal bone loss was significantly correlated with PRC scores. 
The patients with higher PRC scores had more average proximal bone loss when measured 
radiographically.  Average proximal bone loss in the control group was 0.11mm and in the 
peri-implantitis group was 2.48 mm.  
	
Figure	3.	Periapical	radiograph	of	4.3	x	10	mm	Nobel	Biocare,	active	implant	supporting	a	mandibular	fixed	detachable	prosthesis	and	displaying	>50%	bone	loss	on	the	mesial	and	distal	aspects.			
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Figure	4.	(A)	Baseline	radiograph	of	4.3	x	10	mm	Nobel	Replace	implant	restored	with	cement	retained	porcelain	fused	to	metal	crown	#	30.	2-3mm	of	bone	loss	was	noted	after	1	year	of	function	due	to	initial	remodeling.	(B)	Latest	radiograph	made	after	7	years	of	function.	Severe	bone	loss	is	seen	on	the	mesial	and	distal	aspects.	 
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Table 2. Showing patient characteristics for control and test group. 
 
Characteristics Total (N=83 patients 
with 112 implants) 
Control (N=22 patients and 
30 implants) 
Test (N=61 patients and 82 
implants) 
P Value 
 N % N % N %  
Gender 
Female 
Male 
 
47 
36 
 
56.63 
43.37 
 
11 
11 
 
23.40 
30.56 
 
36 
25 
 
76.60 
69.44 
0.4644 
Smoking 
Former Smoker 
Non- Smoker 
Current Smoker 
 
17 
62 
4 
 
20.48 
74.70 
4.82 
 
5 
16 
1 
 
29.41 
25.81 
25.00 
 
12 
46 
3 
 
70.59 
74.19 
75.00 
0.9541 
Diabetes 
No 
Yes 
 
73 
10 
 
87.95 
12.05 
 
18 
4 
 
24.66 
40.00 
 
55 
6 
 
75.34 
60.00 
 
 
0.3026 
Hypertension 
No 
Yes 
 
52 
31 
 
62.65 
37.35 
 
18 
4 
 
34.62 
12.90 
 
 
34 
27 
 
65.38 
87.10 
 
0.0302 
Staging (Implants) 
1 stage 
2 stage 
 
69 
43 
 
61.61 
39.39 
 
16 
14 
 
23.19 
32.56 
 
53 
29 
 
76.81 
67.44 
0.2762 
 
Implant brand 
Astra 
NB 
NB active 
ST BLT 
ST TL 
 
5 
84 
5 
11 
7 
 
4.46 
75.0 
4.46 
9.82 
6.25 
 
2 
16 
0 
10 
2 
 
40.0 
19.16 
0.0 
90.91 
28.57 
 
3 
68 
5 
1 
5 
 
60.0 
80.95 
100.0 
9.09 
71.43 
<0.001 
 
Bone graft before implant 
No 
Yes 
 
87 
25 
 
 
77.68 
22.32 
 
 
21 
9 
 
24.14 
36.00 
 
66 
16 
 
75.86 
64.00 
 
0.2378 
Bone graft at implant 
No 
Yes 
 
74 
38 
 
66.07 
33.93 
 
 
18 
12 
 
 
24.32 
31.58 
 
56 
26 
 
75.68 
68.42 
 
0.4117 
Implant diameter 
Narrow (< 4mm) 
Regular (4-4.5mm) 
Wide (> 4.6mm) 
 
1 
68 
43 
 
0.89 
60.71 
38.39 
 
 
1 
24 
5 
 
100.00 
35.29 
11.63 
 
0 
44 
38 
 
0.00 
64.71 
88.37 
 
0.0059 
PRC 
Score 1 
Score 2 
Score 3 
Score 4 
Score 5 
 
7 
32 
9 
33 
2 
 
8.43 
38.55 
10.84 
39.76 
2.41 
 
 
7 
10 
2 
3 
0 
 
100.00 
31.25 
22.22 
9.09 
0.00 
 
0 
22 
7 
30 
2 
 
0.00 
68.75 
77.78 
90.91 
100.00 
 
 
<.0001 
Placement 
Delayed 
Immediate 
 
92 
20 
 
82.14 
17.86 
 
 
27 
3 
 
29.35 
15.00 
 
 
65 
17 
 
70.65 
85.00 
 
0.1891 
Site 
Ant Mand 
Ant Max 
Post Mand 
Post Max 
 
 
2 
9 
36 
36 
 
2.41 
10.84 
43.37 
43.37 
 
0 
3 
10 
9 
 
0.00 
33.33 
27.78 
25.00 
 
2 
6 
26 
27 
 
100.00 
66.67 
72.22 
75.00 
 
0.7992 
 
 
 
Cement vs screw retained 
restoration 
 
Cement 
Screw 
 
 
74 
9 
 
 
89.16 
10.84 
 
 
 
19 
3 
 
 
25.68 
33.33 
 
 
 
55 
6 
 
 
74.32 
66.67 
 
 
0.6231 
Age (Mean and SD) 68.49 
 
13.68 66.91 15.21 69.07 13.17 0.5295 
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Dependent Variable: Average bone loss 
Source DF Sum of 
Squares 
Mean 
Square 
F Value Pr > F 
Model 4 34.72 8.68 4.06 0.0042 
Error 107 228.90 2.14 
  
Corrected Total 111 263.62 
   
Table 3. ANOVA procedure for average bone loss. 
 
 
PRC N Average bone loss 
Mean Std Dev 
 1 10 0.10 0.14 
 2 47 1.93 1.81 
 3 12 1.87 1.30 
 4 40 2.15 1.23 
 5 3 2.07 0.68 
Table 4. Descriptive statistics for average bone loss across five PRC categories. 
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Figure 5. Box plots for average bone loss across five PRC categories.  
 
 
There was a significant correlation towards increased bone loss measurements as PRC 
scores increased. PRC scores of 4 and 5 experienced the most severe bone loss with an 
average of 2.15 and 2.07mm, respectively. Patients with PRC scores of 1 had minimal to 
no bone loss with an average measurement of 0.10mm.  
The PRC scores showing the highest frequency were 2 and 4. PRC scores of 2 had the 
highest standard deviation while PRC scores of 1 had the lowest. Thus, PRC scores of 1 
consistently showed minimal levels of bone loss while PRC scores of 2 showed high 
variability.  
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Analysis Variable: Follow up Time (Control) 
PRC N Mean Std Dev 
1 10 6.45 2.76 
2 14 5.94 3.08 
3 2 5.36 3.80 
4 4 3.77 1.24 
Table 5. Descriptive statistics for follow up time across PRC categories for control 
group. 
 
 
Analysis Variable: Follow up Time (Test) 
PRC N Mean Std Dev 
2 33 4.19 2.76 
3 10 3.78 2.45 
4 36 3.36 2.28 
5 3 3.49 1.52 
Table 6. Descriptive statistics for follow up time across PRC categories for test group. 
 
 
For the control groups, follow up times where calculated from time of implant placement 
to latest follow-up. For the test group, follow-up was tabulated from the time of implant 
placement until the disease occurrence. Average follow-up times ranged from 3.36-6.45 
years. PRC scores of 4 and 5 had the fastest occurrence of disease from time of implant 
placement. PRC scores of 1 had the longest disease-free follow-up. For the control group 
each PRC category showed a longer average duration of function than the corresponding 
category in the test group. 
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Variable  Reference 
Category 
Hazard ratio 95% Hazard Ratio 
Confidence 
Interval 
P value  
  
Lower         Upper 
Average Bone 
Loss 
 
1.24 1.06 1.45 0.0074 
 1 Stage  2 Stage 1.47 0.81 2.68 0.2070 
Implant brand - 
Astra 
NB 1.49 0.41 5.45 0.5439 
Implant brand- 
NB Active 
NB 1.25 0.27 5.74 0.7721 
Implant brand-
ST BLT 
NB 0.10 0.01 0.81 0.0312 
Implant brand-
ST TL 
NB 1.10 0.41 2.92 0.8476 
PRC score 
 
1.69 1.32 2.16 <.0001 
Bone Grafting 
Before Implant 
Placement  
Y 0.96 0.51 1.79 0.8928 
Diameter - 
Narrow  
Regular 0.00 0.00 0.00 0.9851 
Diameter- Wide  Regular 1.35 0.81 2.23 0.2514 
Bone Grafting at 
the time of 
Implant 
Placement  
No 2.75 1.28 5.94 0.0099 
Delayed Immediate 2.07 0.86 4.96 0.1031 
Screw retained Cement 4.16 1.89 9.16 0.0004 
Table 7. Cox Regression predicting hazards for peri-implantitis. 
 
 
Average bone loss 
Group PRC N  Mean Std Dev 
Control 
  
  
  
1 10 0.1 0.14 
2 14 0.09 0.19 
3 2 0 0 
4 4 0.25 0.35 
Total    30 0.11 0.2 
Table 8. Average bone loss for control group. 
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Average bone loss 
Group PRC N  Mean Std Dev 
Test 
  
  
  
2 33 2.71 1.6 
3 10 2.24 1.06 
4 36 2.36 1.11 
5 3 2.06 0.68 
Total    82 2.48 1.31 
Table 9. Average bone loss for test group.     
 
 
PRC N               Average bone loss  Time to Peri-implantitis  
Mean Std Dev Mean Std Dev 
1 10 0.1 0.14 6.45 2.76 
2 47 1.93 1.81 4.71 2.94 
3 12 1.86 1.30 4.04 2.57 
4 40 2.15 1.23 3.40 2.19 
5 3 2.07 0.68 3.49 1.52 
Table 10. Average bone loss and time to peri-implantitis diagnosis date. 
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DISCUSSION 
The null hypothesis in this study was rejected as the statistical analysis showed that patients 
with higher PRC scores were more likely to have peri-implantitis. This correlation was 
statistically significant and most notable for the high PRC values. Implants with PRC 
values of 1 were negative for peri-implantitis in 100% of the subjects while implants with 
PRC values of 4 and 5 were positive for peri-implantitis in 100% of the subjects. This 
information may be beneficial when planning for implant therapy, especially since the PRC 
can also aid in predicting risk of periodontal disease progression around teeth. PRC 
analysis can help plan therapy for patients with periodontal disease as well as give an 
indication of potential risk of peri-implant disease in these patients.   
 
The results of the current study found that there was no statistically significant difference 
between smokers and non-smokers with regards to prevalence of peri-implantitis.  
 
The results from previous studies such as Haas et al. and Lindquist et al. demonstrated that 
smoking results in higher level of bone loss around implants and that this relationship may 
be dose dependent.36,37 Al Harthi and colleagues, in 2017, showed that in waterpipe 
smoking was also significantly correlated with peri-implantitis.38 The current study did not 
include waterpipe smoking as a separate entity and many waterpipe smokers may not 
consider themselves as smokers. This may underestimate the number of smokers actually 
included in the study.  
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This study did not find a significant correlation between diabetes and peri-implantitis. This 
is in contrast to the results presented by Monje and co-workers in 2017. Their systemic 
review data showed that diabetic patients were at 50% higher risk of developing peri-
implantitis with a dose-dependent relationship to baseline HBA1c level.39  
 
In this study, implant site, bone grafting before or at the time of placement, delayed vs 
immediate placement, 1-stage vs 2-stage procedures did not seem to influence the 
incidence of peri-implantitis. These findings are consistent with the results of Kim and 
colleagues in their retrospective study of 184 implants they found no correlation for any of 
the above-mentioned variables to bone loss around implants.43  
Shin and wo-workers, in 2006, showed reduced crestal bone loss around roughened surface 
implants as compared to machined surface.45 The current study only included roughened 
surface implants, with the exception of the polished collar on Straumann tissue-level 
implants. While different surface treatments may have different biological responses over 
time, most of the implants in the current study where Nobel Biocare implants utilizing the 
same TiUnite surface. Therefore, the impact of different surfaces on the results of this study 
could not be evaluated. The TiUnite surface is a moderately rough titanium oxide layer that 
has been extensively studied and has demonstrated clinical success over time.55 
 
Susarla and colleagues, in 2008, found that immediately loaded implants are 2.7 times more 
likely to fail at 1 year than conventionally loaded implants.47 The current study found no 
such correlation. While several authors stated that crestal bone loss after immediate implant 
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placement is an expected clinical outcome49,51, this was not corroborated by the current 
study.  
 
In the current study, bone grafting before or at the time of implant placement showed no 
correlation to bone loss or the occurrence of peri-implantitis. Whether long term survival 
rates of implants in augmented sites is different from non-augmented sites is still 
controversial.44 Boronat and co-workers in 2010 presented clinical outcomes of 129 
implants placed with simultaneous autogenous block grafts. They found the mean bone 
loss after 1 year of loading to be 0.64 mm.56 Ramanauskaite et. al. in 2018 assessed grafted 
versus non grafted implant sites response to peri-implantitis therapy. Their findings showed 
that combined augmentative therapy with implantoplasty had similar results for implants 
that were placed in grafted and nongrafted sites.57 Lin and co-workers, in 2018, found that 
implant failures after occlusal loading has occurred were significantly more common in 
patients that had bone augmentation procedures done.44 
 
As for soft tissue thickness, a minimum of 2mm is required to reduce chances of crestal 
bone loss according to Linkevicius and colleagues, in 2009. This could not be evaluated in 
the current study.53  
 
The current study found hypertension and implant diameter to be correlated with peri-
implantitis. This may be an overstatement as there are too many confounding factors that 
play a role in the development of this disease.28 Further, most implants included in the study 
were regular and wide diameter with the exception of one narrow diameter implant.  
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It is important to note that due to the strict inclusion criteria and the nature of patients’ 
compliance with follow up appointments within the school, the sample size of this study 
was reduced from what had been anticipated. This may have affected the data and statistical 
analysis leading to possible under or over-estimation of the results. Furthermore, patients 
with a PRC of 1 and 5 had the lowest number of subjects included. This may be due to the 
fact that most patients with PRC 1 don’t have a demand for implants, while most patients 
with PRC 5 may be regarded as poor candidates for implants and so were treated with 
alternative methods.  
 
One main limitation of this study is that it is a single center study where only patients that 
had complete records for analysis were included. Subjects that were included in the study 
had variable follow- up intervals which made it difficult to add a time factor to the analysis 
of bone loss. Had there been more consistent follow up intervals, severity of bone loss in 
relation to time could have been analyzed for each PRC group.  
 
Another limitation is that the technique for radiograph acquisition could not be 
standardized due to the retrospective nature of the study. Further, the measurements were 
made on the available radiographs which were mostly bitewings, and in some instance 
periapical radiographs. This was accounted for by making sure the digital ruler on the 
radiograph was always calibrated before each measurement, using objects of known size.   
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Several other limitations were encountered during the course of this study. Firstly, most 
implants placed in the dental school were Nobel Biocare implants. This led to a significant 
bias towards this implant brand and impeded efforts to perform statistical analysis across 
the different brands of implants in relation to peri-implantitis. Secondly, most of the 
implants restored in the school were restored by pre-doctoral students with minimal 
experience in implant dentistry. Although this process occurs under close supervision of 
the faculty, there may still be a confounding factor that limits generalization of these 
finding to the general public. Moreover, owing to its simplicity, most of the implants were 
restored with cement retained restorations. Excess cement left behind from the cementation 
procedure is a known risk factor for peri-implantitis.29,30 This may be more likely due to 
the already stated inexperience of the students.  It should be noted that excess cement and 
not the cemented restoration itself is the risk factor.  
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SUMMARY AND CONCLUSIONS 
Within the limitations of the study, the following conclusions can be drawn,  
1. Periodontal risk calculator may be used to predict risk of periimplantitis occurrence 
and degree of radiographic proximal bone loss around dental implants.  
2. Higher PRC scores were correlated with higher bone loss and lower PRC scores were 
correlated with reduced severity of bone loss. 
3. Site, bone grafting before or at the time of placement, delayed vs immediate placement, 
1-stage vs 2-stage procedures did not influence incidence of peri-implantitis.  
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